Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1981 1
1987 1
1989 1
1990 2
1991 2
1992 3
1993 1
1994 1
1995 2
1997 1
1998 1
2000 7
2001 2
2002 3
2004 5
2005 6
2006 3
2007 7
2008 12
2009 17
2010 18
2011 17
2012 17
2013 20
2014 25
2015 24
2016 25
2017 35
2018 30
2019 30
2020 30
2021 40
2022 35
2023 64
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

463 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Bardia A, Messersmith WA, Kio EA, Berlin JD, Vahdat L, Masters GA, Moroose R, Santin AD, Kalinsky K, Picozzi V, O'Shaughnessy J, Gray JE, Komiya T, Lang JM, Chang JC, Starodub A, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Wegener WA, Goswami T, Ocean AJ. Bardia A, et al. Ann Oncol. 2021 Jun;32(6):746-756. doi: 10.1016/j.annonc.2021.03.005. Epub 2021 Mar 16. Ann Oncol. 2021. PMID: 33741442 Free article. Clinical Trial.
Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma.
Costa LJ, Chhabra S, Medvedova E, Dholaria BR, Schmidt TM, Godby KN, Silbermann R, Dhakal B, Bal S, Giri S, D'Souza A, Hall A, Hardwick P, Omel J, Cornell RF, Hari P, Callander NS. Costa LJ, et al. J Clin Oncol. 2022 Sep 1;40(25):2901-2912. doi: 10.1200/JCO.21.01935. Epub 2021 Dec 13. J Clin Oncol. 2022. PMID: 34898239 Clinical Trial.
PURPOSE: The MASTER trial combined daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd) in newly diagnosed multiple myeloma (NDMM), using minimal residual disease (MRD) by next-generation sequencing (NGS) to inform the use and duration of Dara-KRd post-auto …
PURPOSE: The MASTER trial combined daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd) in newly diagnosed multiple m …
Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology.
Glide-Hurst CK, Lee P, Yock AD, Olsen JR, Cao M, Siddiqui F, Parker W, Doemer A, Rong Y, Kishan AU, Benedict SH, Li XA, Erickson BA, Sohn JW, Xiao Y, Wuthrick E. Glide-Hurst CK, et al. Int J Radiat Oncol Biol Phys. 2021 Mar 15;109(4):1054-1075. doi: 10.1016/j.ijrobp.2020.10.021. Epub 2020 Oct 24. Int J Radiat Oncol Biol Phys. 2021. PMID: 33470210 Free PMC article. Review.
ZBTB1 Regulates Asparagine Synthesis and Leukemia Cell Response to L-Asparaginase.
Williams RT, Guarecuco R, Gates LA, Barrows D, Passarelli MC, Carey B, Baudrier L, Jeewajee S, La K, Prizer B, Malik S, Garcia-Bermudez J, Zhu XG, Cantor J, Molina H, Carroll T, Roeder RG, Abdel-Wahab O, Allis CD, Birsoy K. Williams RT, et al. Cell Metab. 2020 Apr 7;31(4):852-861.e6. doi: 10.1016/j.cmet.2020.03.008. Cell Metab. 2020. PMID: 32268116 Free PMC article.
Activating transcription factor 4 (ATF4) is a master transcriptional regulator of the integrated stress response (ISR) that enables cell survival under nutrient stress. ...
Activating transcription factor 4 (ATF4) is a master transcriptional regulator of the integrated stress response (ISR) that enables c …
Engineered Collagen Matrices.
Patil VA, Masters KS. Patil VA, et al. Bioengineering (Basel). 2020 Dec 16;7(4):163. doi: 10.3390/bioengineering7040163. Bioengineering (Basel). 2020. PMID: 33339157 Free PMC article. Review.
Fund Black scientists.
Stevens KR, Masters KS, Imoukhuede PI, Haynes KA, Setton LA, Cosgriff-Hernandez E, Lediju Bell MA, Rangamani P, Sakiyama-Elbert SE, Finley SD, Willits RK, Koppes AN, Chesler NC, Christman KL, Allen JB, Wong JY, El-Samad H, Desai TA, Eniola-Adefeso O. Stevens KR, et al. Cell. 2021 Feb 4;184(3):561-565. doi: 10.1016/j.cell.2021.01.011. Epub 2021 Jan 26. Cell. 2021. PMID: 33503447 Free article.
Lysosome: The metabolic signaling hub.
Lamming DW, Bar-Peled L. Lamming DW, et al. Traffic. 2019 Jan;20(1):27-38. doi: 10.1111/tra.12617. Epub 2018 Nov 14. Traffic. 2019. PMID: 30306667 Free PMC article. Review.
This notion has undergone a radical shift in the last 10 years, with new research revealing that this organelle serves as a major hub for metabolic signaling pathways. The discovery that master growth regulators, including the protein kinase mTOR (mechanistic target of rap …
This notion has undergone a radical shift in the last 10 years, with new research revealing that this organelle serves as a major hub for me …
Simulators for Laryngeal and Airway Surgery.
Burns JA, Adkins LK, Dailey S, Klein AM. Burns JA, et al. Otolaryngol Clin North Am. 2017 Oct;50(5):903-922. doi: 10.1016/j.otc.2017.05.003. Epub 2017 Jun 29. Otolaryngol Clin North Am. 2017. PMID: 28669461 Review.
Laryngeal and airway surgery require precise technique and significant mastered skill that can be difficult to obtain during otolaryngology residency training. ...
Laryngeal and airway surgery require precise technique and significant mastered skill that can be difficult to obtain during otolaryn …
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials.
Chhabra S, Callander N, Watts NL, Costa LJ, Thapa B, Kaufman JL, Laubach J, Sborov DW, Reeves B, Rodriguez C, Chari A, Silbermann R, Anderson LD Jr, Bal S, Dhakal B, Nathwani N, Shah N, Medvedova E, Bumma N, Holstein SA, Costello C, Jakubowiak A, Wildes TM, Schmidt T, Orlowski RZ, Shain KH, Cowan AJ, Dholaria B, Cornell RF, Jerkins JH, Pei H, Cortoos A, Patel S, Lin TS, Usmani SZ, Richardson PG, Voorhees PM. Chhabra S, et al. Transplant Cell Ther. 2023 Mar;29(3):174.e1-174.e10. doi: 10.1016/j.jtct.2022.11.029. Epub 2022 Dec 6. Transplant Cell Ther. 2023. PMID: 36494017 Free article.
Therefore, we assessed stem cell mobilization in patients following frontline induction therapy in the MASTER and GRIFFIN phase 2 clinical studies by examining stem cell mobilization yields, apheresis attempts, and engraftment outcomes for patients from each study. ...Desc …
Therefore, we assessed stem cell mobilization in patients following frontline induction therapy in the MASTER and GRIFFIN phase 2 cli …
RNA-editing in Basidiomycota, revisited.
Min B, Wu B, Gaskell J, Zhang J, Toapanta C, Ahrendt S, Blanchette RA, Master E, Cullen D, Hibbett DS, Grigoriev IV. Min B, et al. ISME Commun. 2021 Dec 1;1(1):70. doi: 10.1038/s43705-021-00037-9. ISME Commun. 2021. PMID: 37938697 Free PMC article. No abstract available.
463 results